Collectively, our in vitro analysis indicates that SOX10 suppression by genetic knockdown or TMZ treatment transitioned human and mouse glioblastoma to a qNSC-like cell state, supporting the use of SOX10-KD as an in vitro model for therapy-associated phenotypic transition in glioblastoma. Here, SOX10 is linked to glioblastoma.